Bone Metastasis Epidemiology

Key Highlights

 

• According to the American Cancer Society (ACS), about 400,000 new cases of malignant bone metastasis are diagnosed in the United States, each year.

 

• As per (Coleman et al., 2020), Metastatic bone disease is frequently observed in particular cancer types, especially in metastasis arising from the breast (70%), prostate (85%), lung (40%), and kidney (40%) cancer types. 

 

• Bone Metastasis epidemiology is segmented as Bone Metastatic Diagnosed Prevalence Cases in the Bone Metastatic epidemiology report.

 

Request for Sample Report of  Bone Metastasis Epidemiology

 

DelveInsight's ‘Bone Metastasis Epidemiology Forecast — 2034’ report delivers an in-depth understanding of the disease, historical and forecasted Bone Metastasis epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

 

Geography Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

 

Study Period: 2021-2034

 

Bone Metastasis Epidemiology: Disease Understanding

The DelveInsight’s Bone Metastasis market report gives a thorough understanding of Bone Metastasis by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types of cancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostate cancer.

 

Bone metastasis is classified as osteolytic, osteoblastic, or mixed lesions, according to the primary mechanism of interference with normal bone remodeling. The development of bone metastases can be considered in several stages: colonization, quiescence, progression, either locally leading to overt metastasis in bone or dissemination to another site.

 

Bone metastasis is common and is one of the leading causes of complications in the natural history of cancer. The consequences of bone metastasis may compromise quality of life, limit day-to-day activities, threaten life expectancy, and increase medical intervention and expenses. The complications of bone metastases, usually referred to as skeletal-related events (SREs), include pain, hypercalcemia, bone fractures, and nerve compression that may require radiation therapy (RT) or surgery.

 

Pain is the most common symptom of bone metastases. Other symptoms include fractures, spinal cord compression and high blood calcium levels.

 

Bone Metastasis Diagnosis

The diagnosis is based on signs, symptoms, and imaging; it has major clinical consequences for the patient concerned and, therefore, a timely and definite diagnosis is crucial. The standard of care imaging methods for bone metastases detection includes plain X-ray, computed tomography (CT) scan, and radionuclide bone scintigraphy.

 

Bone Metastasis Epidemiology 

The Bone Metastasis epidemiology section provides insights about historical and current Bone Metastasis patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

 

Key Findings

 

• According to the American Cancer Society (ACS), about 400,000 new cases of malignant bone metastasis are diagnosed in the United States, each year.

 

• As per (Coleman et al., 2020), Metastatic bone disease is frequently observed in particular cancer types, especially in metastasis arising from the breast (70%), prostate (85%), lung (40%), and kidney (40%) cancer types. 

 

• The disease epidemiology covered in the report provides historical as well as forecasted Bone Metastasis epidemiology [segmented as Diagnosed Prevalence of Bone Metastatic in Solid Tumors and Cases of Bone Metastasis by Solid Tumor Type] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2021 to 2034.

 

Country Wise- Bone Metastasis Epidemiology

This section provides glimpse of the Bone Metastasis epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

 

Learn how the therapeutic market will evolve and grow in the coming years: Bone Metastasis Market
 

KOL- Views

To keep up with the current Bone Metastasis patient pool and forecasted trend, we take KOLs and SMEs ' opinions working in the Bone Metastasis domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate the patient pool and forecasted trend.

 

Scope of the Bone Metastasis Epidemiology Report

• The report covers the descriptive overview of Bone Metastasis, explaining their causes, symptoms, pathophysiology, and genetic basis
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan
• The report assesses the disease risk and burden and highlights the unmet needs of Bone Metastasis
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population
• The report provides the segmentation of the disease epidemiology for 7MM by Diagnosed Prevalence of Bone Metastatic in Solid Tumors and Cases of Bone Metastasis by Solid Tumor Type

 

Bone Metastasis Epidemiology Report Highlights

• The companies and academics are working to assess challenges and seek opportunities that could influence Bone Metastasis R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition      
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Bone Metastasis 
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

 

Bone Metastasis Report Insights

• Patient Population
• Therapeutic Approaches

 

Bone Metastasis Report Key Strengths

• 11 Years Forecast
• 7MM Coverage
• Bone Metastasis Epidemiology Segmentation

 

Bone Metastasis Report Assessment

• Disease Understanding
• Current Diagosis Practices and Guidelines
• Epidemiology Trends

 

Key Questions

 

Epidemiology Insights:

• What are the disease risk, burden, and regional/ethnic differences of Bone Metastasis?
• What are the key factors driving the epidemiology trend for seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What is the historical Bone Metastasis patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What would be the forecasted patient pool of Bone Metastasis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• Where will be the growth opportunities in the 7MM concerning the patient population about Bone Metastasis?
• Out of all 7MM countries, which country would have the highest incident population of Bone Metastasis during the forecast period (2025-2034)?
• At what CAGR the patient population is expected to grow by 7MM during the forecast period (2025-2034)?

 

Reasons to buy

• The report will help in developing business strategies by understanding trends shaping and driving the Bone Metastasis Disease market
• To understand the future market competition in the Bone Metastasis Disease market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Bone Metastasis Disease in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom), and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for the Bone Metastasis Disease market
• To understand the future market competition in the Bone Metastasis Disease market